Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tat Technologies (TATT) Other Non Operating Income (2022 - 2025)

Historic Other Non Operating Income for Tat Technologies (TATT) over the last 5 years, with Q3 2025 value amounting to $206000.0.

  • Tat Technologies' Other Non Operating Income rose 16539.68% to $206000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$462000.0, marking a year-over-year decrease of 1696.2%. This contributed to the annual value of -$477000.0 for FY2024, which is 23512.75% down from last year.
  • Per Tat Technologies' latest filing, its Other Non Operating Income stood at $206000.0 for Q3 2025, which was up 16539.68% from -$776000.0 recorded in Q2 2025.
  • Tat Technologies' 5-year Other Non Operating Income high stood at $645000.0 for Q2 2022, and its period low was -$776000.0 during Q2 2025.
  • Moreover, its 4-year median value for Other Non Operating Income was $106000.0 (2024), whereas its average is $40200.0.
  • Over the last 5 years, Tat Technologies' Other Non Operating Income had its largest YoY gain of 36132.08% in 2025, and its largest YoY loss of 83207.55% in 2025.
  • Tat Technologies' Other Non Operating Income (Quarter) stood at -$142000.0 in 2022, then skyrocketed by 43.66% to -$80000.0 in 2023, then tumbled by 111.25% to -$169000.0 in 2024, then surged by 221.89% to $206000.0 in 2025.
  • Its Other Non Operating Income was $206000.0 in Q3 2025, compared to -$776000.0 in Q2 2025 and $277000.0 in Q1 2025.